Metabolites as Prognostic Markers for Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients Treated with First-Line Platinum-Doublet Chemotherapy

The metabolic requirements of metastatic non-small cell lung (mNSCLC) tumors from patients receiving first-line platinum-doublet chemotherapy are hypothesized to imprint a blood signature suitable for survival prediction. Pre-treatment samples prospectively collected at baseline from a randomized ph...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Hao, Desirée, Sengupta, Arjun, Ding, Keyue, Ubeydullah, ER, Krishnaiah, Saikumari, Leighl, Natasha B., Shepherd, Frances A., Seymour, Lesley, Weljie, Aalim
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7409233/
https://ncbi.nlm.nih.gov/pubmed/32708705
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12071926
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados